Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 5Docetaxel 4Cisplatin 4Radiation 2Positron Emission Tomography Computed Tomography 2Immunotherapy 2Fluorouracil 2Drug Therapy 2sintilimab 1neodymium pyrocatechin disulfonate 1X-Rays 1Restraint, Physical 1Quality of Life 1Patient Reported Outcome Measures 1Parenteral Nutrition 1Molecular Diagnostic Techniques 1Liquid Biopsy 1Induction Chemotherapy 1Immune Checkpoint Inhibitors 1Gemcitabine 1G(M1) Ganglioside 1Enteral Nutrition 1Endoscopy 1DMAC2L protein, human 1Chemoradiotherapy 1Capecitabine 1Blood Specimen Collection 1Biopsy 1Biological Therapy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Nasopharyngeal Carcinoma × DMAC2L protein, human × Clear all
NCT05517135 2024-09-19

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

National Cancer Centre, Singapore

Recruiting
1,000 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡